Maud Ward
Internal Medicine · Cheshire, CTNPI 1609822709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,963 and has fallen 88.7% since, to $223 in 2024. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $32.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Novo Nordisk$556
- AstraZeneca$491
- Lilly USA, LLC$437
- AbbVie$434
- Johnson & Johnson$353
- plus $3K from 21 others
What the payments were for
- Food & beverage$6,076100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 29 | $1,231 |
| Novo Nordisk | 7 | $556 |
| AstraZeneca | 14 | $491 |
| Lilly USA, LLC | 23 | $437 |
| AbbVie(2 entities) | 22 | $434 |
| Johnson & Johnson | 20 | $353 |
| Vifor Pharma, Inc. | 3 | $351 |
| Bayer | 4 | $311 |
| Teva Pharmaceuticals USA, Inc. | 14 | $303 |
| Boehringer Ingelheim | 7 | $245 |
| Arbor Pharmaceuticals, Inc. | 11 | $191 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $151 |
| Merck | 3 | $130 |
| Portola Pharmaceuticals, LLC | 1 | $125 |
| Pfizer | 4 | $119 |
| Novartis | 2 | $116 |
| Lexicon Pharmaceuticals, Inc. | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $98 |
| Biohaven Pharmaceuticals, Inc. | 4 | $95 |
| Amarin Pharma, Inc. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,081 in reported general payments places this provider in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Cheshire
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Nicholas DainiakBridgeport$352K
- Thomas PellechiGreenwich$196K
- John PriceGlastonbury$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.